LIRUM

Live / Applied — Third extension granted (statement of use) (as of 21 Jan 2026)

What this means for you

Not registered yet, but its 09 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97926852
Mark type
Stylized text
Filed
09 May 2023
Published for opposition
28 May 2024
Attorney of record
Nadya M. Sand

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for human use for the treatment and prevention of diseases and disorders, namely, oncology, neurodegenerative, ophthalmology, autoimmune, debilitating, degenerative, and infectious diseases and disorders; pharmaceuticals for human use, namely, oncology, neurodegenerative, ophthalmology and autoimmune pharmaceuticals; pharmaceuticals for the treatment of debilitating, degenerative, and infectious diseases
  • Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; consulting services for others in the field of design, planning, implementation, and project management of clinical trials; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals, therapeutics, clinical trials, and studies; testing of pharmaceuticals, biopharmaceuticals, therapeutics, and drugs; research and development of pharmaceuticals, biopharmaceuticals, therapeutics, and drugs; consulting in the field of pharmaceutical, biopharmaceutical, and biotech drug development services; clinical and scientific research and development in the field of pharmaceuticals and biopharmaceuticals; providing medical and scientific research information and data relating to pharmaceuticals, biopharmaceuticals, therapeutics, and medical and scientific research and development; research and development of pharmaceuticals and drug candidates

Owner

Prosecution history

  • 22 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 21 Jan 2026 — SOU EXTENSION 3 GRANTED
  • 21 Jan 2026 — SOU EXTENSION 3 FILED
  • 21 Jan 2026 — SOU TEAS EXTENSION RECEIVED
  • 16 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 15 Jul 2025 — SOU EXTENSION 2 GRANTED
  • 15 Jul 2025 — SOU EXTENSION 2 FILED
  • 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 22 Jan 2025 — SOU EXTENSION 1 GRANTED
  • 21 Jan 2025 — SOU EXTENSION 1 FILED
  • 21 Jan 2025 — SOU TEAS EXTENSION RECEIVED
  • 23 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 28 May 2024 — PUBLISHED FOR OPPOSITION

View this trademark record on Marksy